These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22087639)

  • 1. Hot spots and transient pockets: predicting the determinants of small-molecule binding to a protein-protein interface.
    Metz A; Pfleger C; Kopitz H; Pfeiffer-Marek S; Baringhaus KH; Gohlke H
    J Chem Inf Model; 2012 Jan; 52(1):120-33. PubMed ID: 22087639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and computational active site mapping as a starting point to fragment-based lead discovery.
    Behnen J; Köster H; Neudert G; Craan T; Heine A; Klebe G
    ChemMedChem; 2012 Feb; 7(2):248-61. PubMed ID: 22213702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational detection of the binding-site hot spot at the remodeled human growth hormone-receptor interface.
    Verkhivker GM; Bouzida D; Gehlhaar DK; Rejto PA; Freer ST; Rose PW
    Proteins; 2003 Nov; 53(2):201-19. PubMed ID: 14517972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-protein interactions: hot spots and structurally conserved residues often locate in complemented pockets that pre-organized in the unbound states: implications for docking.
    Li X; Keskin O; Ma B; Nussinov R; Liang J
    J Mol Biol; 2004 Nov; 344(3):781-95. PubMed ID: 15533445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
    Fauman EB; Rai BK; Huang ES
    Curr Opin Chem Biol; 2011 Aug; 15(4):463-8. PubMed ID: 21704549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From determinants of RUNX1/ETO tetramerization to small-molecule protein-protein interaction inhibitors targeting acute myeloid leukemia.
    Metz A; Schanda J; Grez M; Wichmann C; Gohlke H
    J Chem Inf Model; 2013 Sep; 53(9):2197-202. PubMed ID: 23957251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo simulations of the peptide recognition at the consensus binding site of the constant fragment of human immunoglobulin G: the energy landscape analysis of a hot spot at the intermolecular interface.
    Verkhivker GM; Bouzida D; Gehlhaar DK; Rejto PA; Freer ST; Rose PW
    Proteins; 2002 Aug; 48(3):539-57. PubMed ID: 12112677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory computational assessment of possible binding modes for small molecule inhibitors of the CD40-CD154 co-stimulatory interaction.
    Ganesan L; Vidović D; Schürer SC; Buchwald P
    Pharmazie; 2012 May; 67(5):374-9. PubMed ID: 22764566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of MM-PBSA rescoring of docking poses.
    Thompson DC; Humblet C; Joseph-McCarthy D
    J Chem Inf Model; 2008 May; 48(5):1081-91. PubMed ID: 18465849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
    Jain V; Saravanan P; Arvind A; Mohan CG
    Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a rule-based method for the assessment of protein druggability.
    Perola E; Herman L; Weiss J
    J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Computational Investigation of Small-Molecule Engagement of Hot Spots at Protein-Protein Interaction Interfaces.
    Xu D; Si Y; Meroueh SO
    J Chem Inf Model; 2017 Sep; 57(9):2250-2272. PubMed ID: 28766941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational approaches to identifying and characterizing protein binding sites for ligand design.
    Henrich S; Salo-Ahen OM; Huang B; Rippmann FF; Cruciani G; Wade RC
    J Mol Recognit; 2010; 23(2):209-19. PubMed ID: 19746440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based computational approaches for small-molecule modulation of protein-protein interactions.
    Xu D; Wang B; Meroueh SO
    Methods Mol Biol; 2015; 1278():77-92. PubMed ID: 25859944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent small-molecule binding to a dynamic hot spot on IL-2.
    Thanos CD; Randal M; Wells JA
    J Am Chem Soc; 2003 Dec; 125(50):15280-1. PubMed ID: 14664558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blind predictions of protein interfaces by docking calculations in CAPRI.
    Lensink MF; Wodak SJ
    Proteins; 2010 Nov; 78(15):3085-95. PubMed ID: 20839234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient pockets on XIAP-BIR2: toward the characterization of putative binding sites of small-molecule XIAP inhibitors.
    Eyrisch S; Medina-Franco JL; Helms V
    J Mol Model; 2012 May; 18(5):2031-42. PubMed ID: 21877153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.